Florida-based network of outpatient vascular centers partners with 2 private equity investment firms

American Vascular Associates (AVA), a Palm Harbor, Florida-based network of outpatient vascular and endovascular facilities, has received a significant boost from two private equity investment firms.

The company, first launched back in 2008, has completed a growth recapitalization courtesy of investments from Nashville-based Petra Capital Partners and Tampa-based Canopy Capital Partners. AVA plans to use this new funding to accelerate its growth and partner with more physicians.

AVA currently manages outpatient centers in Florida, Delaware, Georgia, Indiana, Mississippi, North Carolina, Texas and Virginia. The group works with nearly 100 interventional cardiologists, radiologists, nephrologists and vascular surgeons to try and meet the rising demand of outpatient office-based labs and ambulatory surgery centers in the United States.

“After an exhaustive national search for the right partner, we are thrilled that both Petra Capital and Canopy Capital made the decision to take this journey with us,” Jan Dees, founder and CEO of American Vascular Associates, said in a prepared statement. “Together, with our new financial partners and the existing AVA team, who will remain shareholders in AVA, we will be well-positioned to positively impact our growth trajectory by providing an outpatient alternative to hospital-based procedures which allows for an improved patient experience, particularly in underserved communities.”

“When we met the team at American Vascular and heard their vision for growth and quality, we felt it would make a great partnership,” added David Fitzgerald, a partner with Petra Capital. “The opportunity to provide better care for patients in lower cost settings fits squarely within Petra’s healthcare investment thesis.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.